RGNX — REGENXBIO INC

Ownership history in Caption Management, LLC  ·  42 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in REGENXBIO INC (RGNX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2021 Q3)
Avg. % of fund
0.01%
First filed
2020 Q3
Last filed
2025 Q4
Quarters held
42
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 30,000 — 0% 0.00% $432K $14.40
2025 Q4 ADDED 30,000 +25,877 +627.6% 0.00% $432K $14.40
2025 Q3 REDUCED 4,123 -25,877 -86.3% 0.00% $40K $9.65
2025 Q3 UNCHANGED 30,000 — 0% 0.00% $290K $9.65
38 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RGNX price (monthly, adj. close)

Other funds also holding RGNX

As of 2025 Q4 — sorted by position size

22NW, LP 3Y 7Y 5.6% Redmile Group, LLC 3Y 7Y 4.63% Lion Point Capital, LP 3Y 7Y 1.98% Propel Bio Management, LLC 1.44% Integral Health Asset Management, LLC 3Y 0.86% ArchPoint Investors 3Y 7Y 0.76% GSK plc 0.49% Pale Fire Capital SE 3Y 0.48% Voss Capital, LP 3Y 0.2% ADAR1 Capital Management, LLC 0.15%
← Back to Caption Management, LLC Holdings